Eagle Health Investments LP
13F Reported Value
ⓘ$571.8M
incl. option notional
Equity Holdings
ⓘ$476.3M
Option Notional
ⓘ$95.5M
$93.2M puts / $2.3M calls
Holdings
28
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Eagle Health Investments LP disclosed 28 positions worth $571.8M in its Form 13F-HR for Q1 2026 — $476.3M in common stock plus $95.5M of put/call option positions (reported at underlying notional value, not premium at risk), followed by $ARGX and $ICLR. During the quarter the fund opened 7 new positions and exited 9 and a full exit from $NBIX. The portfolio is most concentrated in Healthcare (92.7% of disclosed assets). All figures are sourced directly from Eagle Health Investments LP’s Form 13F-HR filing with the SEC under CIK 1842545.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
SPDR SERIES TRUST PUT
—Quality
$93.2M730,000 sh- —
Quality
$55.7M76,336 sh - —
Quality
$39.7M358,500 sh - 29.4
Quality
$36.7M224,271 sh - 36.1
Quality
$28.7M310,281 sh - 74.1
Quality
$28.6M505,809 sh - 46.4
Quality
$24.4M121,877 sh - —
Quality
$24.3M494,019 sh - 62.5
Quality
$23.1M187,413 sh - —
Quality
$21.7M412,497 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| SPDR SERIES TRUST PUT | — | $93.2M | 730,000 |
 ARGENX SE$ARGX | — | $55.7M | 76,336 |
 ICON PLC$ICLR | — | $39.7M | 358,500 |
 INSMED Inc$INSM | 29.4 | $36.7M | 224,271 |
 Guardant Health, Inc.$GH | 36.1 | $28.7M | 310,281 |
 BIOMARIN PHARMACEUTICAL INC$BMRN | 74.1 | $28.6M | 505,809 |
 Natera, Inc.$NTRA | 46.4 | $24.4M | 121,877 |
 Scholar Rock Holding Corp$SRRK | — | $24.3M | 494,019 |
 ILLUMINA, INC.$ILMN | 62.5 | $23.1M | 187,413 |
 Terns Pharmaceuticals, Inc.$TERN | — | $21.7M | 412,497 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Eagle Health Investments LP's 28 positions.
Showing top 10 of 28 holdings.
Sector Allocation
Healthcare
$441.6M
Technology
$34.7M
Full Holdings — Eagle Health Investments LP (Q1 2026)
All 28 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | SPDR SERIES TRUST | $93.2M | — | NEW | — |
| 2 | $ARGX | ARGENX SE | $55.7M | 11.7% | +22% | — |
| 3 | $ICLR | ICON PLC | $39.7M | 8.3% | +45% | — |
| 4 | $INSM | INSMED Inc | $36.7M | 7.7% | +6% | 29.4 |
| 5 | $GH | Guardant Health, Inc. | $28.7M | 6.0% | +9% | 36.1 |
| 6 | $BMRN | BIOMARIN PHARMACEUTICAL INC | $28.6M | 6.0% | +38% | 74.1 |
| 7 | $NTRA | Natera, Inc. | $24.4M | 5.1% | -33% | 46.4 |
| 8 | $SRRK | Scholar Rock Holding Corp | $24.3M | 5.1% | +36% | — |
| 9 | $ILMN | ILLUMINA, INC. | $23.1M | 4.8% | -19% | 62.5 |
| 10 | $TERN | Terns Pharmaceuticals, Inc. | $21.7M | 4.6% | +50% | — |
| 11 |  $BBIO | BridgeBio Pharma, Inc. | $19.8M | 4.2% | +3% | 31.7 |
| 12 |  $ASND | Ascendis Pharma A/S | $19.8M | 4.2% | NEW | 41.5 |
| 13 |  $PTGX | Protagonist Therapeutics, Inc | $18.9M | 4.0% | +213% | 24.8 |
| 14 |  $RARE | Ultragenyx Pharmaceutical Inc. | $18.5M | 3.9% | NEW | 31 |
| 15 |  $BSX | BOSTON SCIENTIFIC CORP | $18.4M | 3.9% | NEW | 79.9 |
| 16 |  $FTRE | Fortrea Holdings Inc. | $12.3M | 2.6% | +7% | 31.4 |
| 17 |  $KYMR | Kymera Therapeutics, Inc. | $12.1M | 2.5% | +7% | 29.2 |
| 18 |  $PRCT | PROCEPT BioRobotics Corp | $12.1M | 2.5% | +57% | 34.8 |
| 19 |  $RVMD | Revolution Medicines, Inc. | $11.6M | 2.4% | +3% | — |
| 20 |  $TEM | Tempus AI, Inc. | $11.6M | 2.4% | NEW | 38.2 |
| 21 |  $CMPS | COMPASS Pathways plc | $11.4M | 2.4% | +36% | — |
| 22 |  $CNTA | Centessa Pharmaceuticals plc | $8.5M | 1.8% | +108% | — |
| 23 |  $ALKS | Alkermes plc. | $8.4M | 1.8% | +192% | — |
| 24 |  $ATAI | Atai Beckley N.V. | $6.1M | 1.3% | +2% | — |
| 25 | $PRCTCALL | PROCEPT BioRobotics Corp | $2.3M | — | NEW | 34.8 |
| 26 |  $ISRG | INTUITIVE SURGICAL INC | $2.0M | 0.4% | +0% | 81.4 |
| 27 |  $IMCR | Immunocore Holdings plc | $1.4M | 0.3% | +0% | — |
| 28 |  $PCSC | Perceptive Capital Solutions Corp | $413,415 | 0.1% | NEW | — |
New Positions (7)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Eagle Health Investments LP including:
Track Eagle Health Investments LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Eagle Health Investments LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Eagle Health Investments LP
13F Pro is an AI hedge fund tracker and stock research platform. For Eagle Health Investments LP (SEC CIK: 1842545), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Eagle Health Investments LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.